Higginsianins A and B, two fungal diterpenoid α-pyrones with cytotoxic activity against human cancer cells.


Journal

Toxicology in vitro : an international journal published in association with BIBRA
ISSN: 1879-3177
Titre abrégé: Toxicol In Vitro
Pays: England
ID NLM: 8712158

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 30 04 2019
revised: 12 07 2019
accepted: 28 07 2019
pubmed: 7 8 2019
medline: 25 3 2020
entrez: 7 8 2019
Statut: ppublish

Résumé

Two new diterpenoid α-pyrones, named higginsianins A and B, were isolated from the mycelium of the microbial fungus Colletotrichum higginsianum grown in liquid culture. In previous studies, we have shown that both compounds reduce viability of different types of cancer cells in culture. Here, we extend our previous observations and explore, at a deeper level, the cellular effects of higginsianins treatment. Higginisianins A and B reduce viability of A431, HeLa and H1299 cancer cells. Both compounds increase the level of the cell cycle inhibitor p21WAF and reduce the rate of cell proliferation. Cell cycle analyses reveal that higginsianins arrest cancer cells in S-phase. Furthermore, cells incubated with higginsianins reveal discrete γ-H2AX positive nuclear foci indicating the occurrence of DNA lesions. At longer incubation times, higginsianins induce massive cell detachment and non-apoptotic cell death. Human primary keratinocytes and spontaneously immortalized Hacat cells, a preneoplastic cell line model, are less sensitive to higginsianins effects. These findings suggest that higginsianins exhibit considerable cytotoxicity against a wide spectrum of malignant cells and may be considered as promising anticancer agents.

Identifiants

pubmed: 31386879
pii: S0887-2333(19)30336-4
doi: 10.1016/j.tiv.2019.104614
pii:
doi:

Substances chimiques

Antineoplastic Agents 0
Diterpenes 0
higginsianin A 0
higginsianin B 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104614

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Felicia Sangermano (F)

Department of Biology, University of Naples Federico II, Via Cintia 4, 80126 Naples, Italy.

Marco Masi (M)

Department of Chemical Sciences, University of Naples Federico II, Via Cintia 4, 80126 Naples, Italy.

Maria Vivo (M)

Department of Biology, University of Naples Federico II, Via Cintia 4, 80126 Naples, Italy.

Peravali Ravindra (P)

Institute of Toxicology and Genetics (ITG), Karlsruhe Institute of Technology, Karlsruhe, Germany.

Alessio Cimmino (A)

Department of Chemical Sciences, University of Naples Federico II, Via Cintia 4, 80126 Naples, Italy.

Alessandra Pollice (A)

Department of Biology, University of Naples Federico II, Via Cintia 4, 80126 Naples, Italy.

Antonio Evidente (A)

Department of Chemical Sciences, University of Naples Federico II, Via Cintia 4, 80126 Naples, Italy.

Viola Calabrò (V)

Department of Biology, University of Naples Federico II, Via Cintia 4, 80126 Naples, Italy. Electronic address: viola.calabro@unina.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH